TLRY — Tilray Brands, Inc.
$2.81-4.10%
Last close: · regular session
Last 60 sessions
TLRY closed at $2.81 (-4.10%) on Oct 23, 2026. Active automatic shelf (S-3ASR, Oct 2025). Float: 100.4M shares. Latest SEC filing: ARS on Sep 28, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for TLRY in the TickerWise workspace.
Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.
Company profile
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Country: CA
- Exchange: NASDAQ Global Select
- Employees: 2,650
- Website: https://www.tilray.com
Latest SEC filings for TLRY
Latest TLRY news
- Tilray Now Sells More Beer Than Cannabis. Here's Why That Might Be Good News for Investors. Read article
- Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026? Read article
- BrewDog Acquisition Boosts Tilray's Q1 Performance Read article
- Tilray Q1: Not Looking Good, Remains A 'Hold' Read article
- 3 Huge Red Flags From Tilray's Q1 Earnings Report Read article
- 3 Reasons I'm Still Not Buying Tilray Stock -- Even at Penny-Stock Prices Read article
- Tilray reaffirms FY2027 adjusted EBITDA guidance of $68M-$75M while integrating BrewDog and preparing for Carlsberg deal Read article
- Tilray Brands, Inc. (TLRY) Q1 2027 Earnings Call Transcript Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.